Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Dietary Patterns Emphasizing the Consumption of Plant Foods in the Management of Type 2 Diabetes: A Narrative Review.

Salas-Salvadó J, Becerra-Tomás N, Papandreou C, Bulló M.

Adv Nutr. 2019 Nov 1;10(Supplement_4):S320-S331. doi: 10.1093/advances/nmy102.

PMID:
31728494
2.

Legume Consumption and Cardiometabolic Health.

Becerra-Tomás N, Papandreou C, Salas-Salvadó J.

Adv Nutr. 2019 Nov 1;10(Supplement_4):S437-S450. doi: 10.1093/advances/nmz003.

PMID:
31728491
3.

Infections Due to Multidrug-Resistant Bacteria in Oncological Patients: Insights from a Five-Year Epidemiological and Clinical Analysis.

Perdikouri EIA, Arvaniti K, Lathyris D, Apostolidou Kiouti F, Siskou E, Haidich AB, Papandreou C.

Microorganisms. 2019 Aug 21;7(9). pii: E277. doi: 10.3390/microorganisms7090277.

4.

High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial.

Liu X, Zheng Y, Guasch-Ferré M, Ruiz-Canela M, Toledo E, Clish C, Liang L, Razquin C, Corella D, Estruch R, Fito M, Gómez-Gracia E, Arós F, Ros E, Lapetra J, Fiol M, Serra-Majem L, Papandreou C, Martínez-González MA, Hu FB, Salas-Salvadó J.

Nutr Metab Cardiovasc Dis. 2019 Oct;29(10):1040-1049. doi: 10.1016/j.numecd.2019.06.005. Epub 2019 Jun 20.

PMID:
31377179
5.

Long Daytime Napping Is Associated with Increased Adiposity and Type 2 Diabetes in an Elderly Population with Metabolic Syndrome.

Papandreou C, Díaz-López A, Babio N, Martínez-González MA, Bulló M, Corella D, Fitó M, Romaguera D, Vioque J, Alonso-Gómez ÁM, Wärnberg J, Martínez AJ, Serra-Majem L, Estruch R, Fernández-García JC, Lapetra J, Pintó X, Tur JA, Garcia-Rios A, Bueno-Cavanillas A, Delgado-Rodríguez M, Matía-Martín P, Daimiel L, Martín-Sánchez V, Vidal J, Vázquez C, Ros E, Buil-Cosiales P, Becerra-Tomas N, Martinez-Lacruz R, Schröder H, Konieczna J, Garcia-de-la-Hera M, Moreno-Rodriguez A, Barón-López J, Pérez-Farinós N, Abete I, Bautista-Castaño I, Casas R, Muñoz-Garach A, Santos-Lozano JM, Trias F, Gallardo-Alfaro L, Ruiz-Canela M, Barragan R, Goday A, Galmés-Panadés AM, González-Botella A, Vaquero-Luna J, Toledo E, Castañer O, Salas-Salvadó J.

J Clin Med. 2019 Jul 19;8(7). pii: E1053. doi: 10.3390/jcm8071053.

6.

Plasma Metabolites Associated with Frequent Red Wine Consumption: A Metabolomics Approach within the PREDIMED Study.

Hernández-Alonso P, Papandreou C, Bulló M, Ruiz-Canela M, Dennis C, Deik A, Wang DD, Guasch-Ferré M, Yu E, Toledo E, Razquin C, Corella D, Estruch R, Ros E, Fitó M, Arós F, Fiol M, Serra-Majem L, Liang L, Clish CB, Martínez-González MA, Hu FB, Salas-Salvadó J.

Mol Nutr Food Res. 2019 Sep;63(17):e1900140. doi: 10.1002/mnfr.201900140. Epub 2019 Jul 17.

PMID:
31291050
7.

High sleep variability predicts a blunted weight loss response and short sleep duration a reduced decrease in waist circumference in the PREDIMED-Plus Trial.

Papandreou C, Bulló M, Díaz-López A, Martínez-González MA, Corella D, Castañer O, Vioque J, Romaguera D, Martínez AJ, Pérez-Farinós N, López-Miranda J, Estruch R, Bueno-Cavanillas A, Alonso-Gómez A, Tur JA, Tinahones FJ, Serra-Majem L, Martin V, Lapetra J, Vazquez C, Pintó X, Vidal J, Damiel L, Delgado-Rodriguez M, Ros E, Abete I, Barón-López J, Garcia-Arellano A, Sorli JV, Babio N, Schröder H, Toledo E, Fitó M, Salas-Salvadó J.

Int J Obes (Lond). 2019 Jun 19. doi: 10.1038/s41366-019-0401-5. [Epub ahead of print]

PMID:
31217539
8.

Plasma Metabolites Associated with Coffee Consumption: A Metabolomic Approach within the PREDIMED Study.

Papandreou C, Hernández-Alonso P, Bulló M, Ruiz-Canela M, Yu E, Guasch-Ferré M, Toledo E, Dennis C, Deik A, Clish C, Razquin C, Corella D, Estruch R, Ros E, Fitó M, Arós F, Fiol M, Lapetra J, Ruano C, Liang L, Martínez-González MA, Hu FB, Salas-Salvadó J.

Nutrients. 2019 May 8;11(5). pii: E1032. doi: 10.3390/nu11051032.

9.

Sleep Duration is Inversely Associated with Serum Uric Acid Concentrations and Uric Acid to Creatinine Ratio in an Elderly Mediterranean Population at High Cardiovascular Risk.

Papandreou C, Babio N, Díaz-López A, Martínez-González MÁ, Becerra-Tomas N, Corella D, Schröder H, Romaguera D, Vioque J, Alonso-Gómez ÁM, Wärnberg J, Martínez AJ, Serra-Majem L, Estruch R, Muñoz-Garach A, Lapetra J, Pintó X, Tur JA, Garcia-Rios A, Bueno-Cavanillas A, Delgado-Rodríguez M, Matía-Martín P, Daimiel L, M Sánchez V, Vidal J, Vázquez C, Ros E, Ruiz-Canela M, Bulló M, Sorli JV, Quifer M, Colom A, Oncina-Canovas A, T Sierra L, Barón-López J, Pérez-Farinós N, Abete I, Sanchez-Villegas A, Casas R, F García JC, Santos-Lozano JM, Corbella E, Del M Bibiloni M, Diez-Espino J, Asensio EM, Torras L, Morey M, Compañ-Gabucio L, S Lete I, Cenoz-Osinaga JC, Castañer O, Salas-Salvadó J.

Nutrients. 2019 Apr 1;11(4). pii: E761. doi: 10.3390/nu11040761.

10.

Fatty Acids Composition of Blood Cell Membranes and Peripheral Inflammation in the PREDIMED Study: A Cross-Sectional Analysis.

Muralidharan J, Papandreou C, Sala-Vila A, Rosique-Esteban N, Fitó M, Estruch R, Angel Martínez-González M, Corella D, Ros E, Razquín C, Castañer O, Salas-Salvadó J, Bulló M.

Nutrients. 2019 Mar 7;11(3). pii: E576. doi: 10.3390/nu11030576.

11.

Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism.

Papandreou C, Li J, Liang L, Bulló M, Zheng Y, Ruiz-Canela M, Yu E, Guasch-Ferré M, Razquin C, Clish C, Corella D, Estruch R, Ros E, Fitó M, Arós F, Serra-Majem L, Rosique N, Martínez-González MA, Hu FB, Salas-Salvadó J.

Sci Rep. 2019 Feb 27;9(1):2892. doi: 10.1038/s41598-019-39441-6.

12.

Plasma metabolites predict both insulin resistance and incident type 2 diabetes: a metabolomics approach within the Prevención con Dieta Mediterránea (PREDIMED) study.

Papandreou C, Bulló M, Ruiz-Canela M, Dennis C, Deik A, Wang D, Guasch-Ferré M, Yu E, Razquin C, Corella D, Estruch R, Ros E, Fitó M, Fiol M, Liang L, Hernández-Alonso P, Clish CB, Martínez-González MA, Hu FB, Salas-Salvadó J.

Am J Clin Nutr. 2019 Mar 1;109(3):626-634. doi: 10.1093/ajcn/nqy262.

PMID:
30796776
13.

Association Between Fatty Acids of Blood Cell Membranes and Incidence of Coronary Heart Disease.

Papandreou C, Sala-Vila A, Galié S, Muralidharan J, Estruch R, Fitó M, Razquin C, Corella D, Ros E, Timiraos J, Lapetra J, Serra-Majem L, Carlos S, Castañer O, Asensio EM, Salas-Salvadó J, Bulló M.

Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):819-825. doi: 10.1161/ATVBAHA.118.312073.

PMID:
30727755
14.

Circulating metabolites associated with objectively measured sleep duration and sleep variability in overweight/obese participants: a metabolomics approach within the SATIN study.

Papandreou C, Camacho-Barcia L, García-Gavilán J, Hansen TT, Hjorth MF, Halford JCG, Salas-Salvadó J, Sjödin A, Bulló M.

Sleep. 2019 May 1;42(5). pii: zsz030. doi: 10.1093/sleep/zsz030.

PMID:
30722060
15.

Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model.

Kamposioras K, Tsimplouli C, Verbeke C, Anthoney A, Daoukopoulou A, Papandreou CN, Sakellaridis N, Vassilopoulos G, Potamianos SP, Liakouli V, Migneco G, Del Galdo F, Dimas K.

Int J Oncol. 2019 Feb;54(2):537-549. doi: 10.3892/ijo.2018.4640. Epub 2018 Nov 21.

16.

Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.

Guasch-Ferré M, Ruiz-Canela M, Li J, Zheng Y, Bulló M, Wang DD, Toledo E, Clish C, Corella D, Estruch R, Ros E, Fitó M, Arós F, Fiol M, Lapetra J, Serra-Majem L, Liang L, Papandreou C, Dennis C, Martínez-González MA, Hu FB, Salas-Salvadó J.

J Clin Endocrinol Metab. 2019 May 1;104(5):1508-1519. doi: 10.1210/jc.2018-01000.

17.

Primitive neuroectodermal tumor transformation of testicular teratoma.

Karatzas A, Papadopoulos V, Katsiouli V, Pisters L, Papandreou C, Tzortzis V.

Urol Ann. 2018 Oct-Dec;10(4):413-415. doi: 10.4103/UA.UA_182_17.

18.

Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial.

Razquin C, Toledo E, Clish CB, Ruiz-Canela M, Dennis C, Corella D, Papandreou C, Ros E, Estruch R, Guasch-Ferré M, Gómez-Gracia E, Fitó M, Yu E, Lapetra J, Wang D, Romaguera D, Liang L, Alonso-Gómez A, Deik A, Bullo M, Serra-Majem L, Salas-Salvadó J, Hu FB, Martínez-González MA.

Diabetes Care. 2018 Dec;41(12):2617-2624. doi: 10.2337/dc18-0840. Epub 2018 Oct 16.

19.

Cross-sectional associations of objectively-measured sleep characteristics with obesity and type 2 diabetes in the PREDIMED-Plus trial.

Rosique-Esteban N, Papandreou C, Romaguera D, Warnberg J, Corella D, Martínez-González MÁ, Díaz-López A, Estruch R, Vioque J, Arós F, Garcia-Rios A, Bueno-Cavanillas A, Vidal J, Serra-Majem L, Sibai AA, Tinahones FJ, Martínez JA, Ordovás JM, Tur JA, Ellacuría MT, Sanllorente A, Pintó X, Buil-Cosiales P, Fernández-Carrion R, Castañer O, Bulló M, Ruiz-Canela M, Garcia-de la Hera M, Pérez-Farinós N, Barón-López FJ, Colom A, Abete I, Ros E, Salas-Salvadó J.

Sleep. 2018 Dec 1;41(12). doi: 10.1093/sleep/zsy190.

PMID:
30285250
20.

Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial.

Yu E, Ruiz-Canela M, Razquin C, Guasch-Ferré M, Toledo E, Wang DD, Papandreou C, Dennis C, Clish C, Liang L, Bullo M, Corella D, Fitó M, Gutiérrez-Bedmar M, Lapetra J, Estruch R, Ros E, Cofán M, Arós F, Romaguera D, Serra-Majem L, Sorlí JV, Salas-Salvadó J, Hu FB, Martínez-González MA.

Diabetes Obes Metab. 2019 Feb;21(2):397-401. doi: 10.1111/dom.13514. Epub 2018 Oct 2.

PMID:
30146690
21.

Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial.

Papandreou C, Bulló M, Zheng Y, Ruiz-Canela M, Yu E, Guasch-Ferré M, Toledo E, Clish C, Corella D, Estruch R, Ros E, Fitó M, Arós F, Fiol M, Lapetra J, Serra-Majem L, Gómez-Gracia E, Liang L, Fragkiadakis GA, Razquin C, Hu FB, Salas-Salvadó J.

Am J Clin Nutr. 2018 Jul 1;108(1):163-173. doi: 10.1093/ajcn/nqy058.

PMID:
29982310
22.

Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case-Cohort Study.

Yu E, Papandreou C, Ruiz-Canela M, Guasch-Ferre M, Clish CB, Dennis C, Liang L, Corella D, Fitó M, Razquin C, Lapetra J, Estruch R, Ros E, Cofán M, Arós F, Toledo E, Serra-Majem L, Sorlí JV, Hu FB, Martinez-Gonzalez MA, Salas-Salvado J.

Clin Chem. 2018 Aug;64(8):1211-1220. doi: 10.1373/clinchem.2018.288720. Epub 2018 Jun 8.

23.

Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial.

Ruiz-Canela M, Guasch-Ferré M, Toledo E, Clish CB, Razquin C, Liang L, Wang DD, Corella D, Estruch R, Hernáez Á, Yu E, Gómez-Gracia E, Zheng Y, Arós F, Romaguera D, Dennis C, Ros E, Lapetra J, Serra-Majem L, Papandreou C, Portoles O, Fitó M, Salas-Salvadó J, Hu FB, Martínez-González MA.

Diabetologia. 2018 Jul;61(7):1560-1571. doi: 10.1007/s00125-018-4611-5. Epub 2018 Apr 16.

24.

Legume consumption and risk of all-cause, cardiovascular, and cancer mortality in the PREDIMED study.

Papandreou C, Becerra-Tomás N, Bulló M, Martínez-González MÁ, Corella D, Estruch R, Ros E, Arós F, Schroder H, Fitó M, Serra-Majem L, Lapetra J, Fiol M, Ruiz-Canela M, Sorli JV, Salas-Salvadó J.

Clin Nutr. 2019 Feb;38(1):348-356. doi: 10.1016/j.clnu.2017.12.019. Epub 2018 Jan 9.

PMID:
29352655
25.

Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFκB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression.

Mitrakas L, Gravas S, Papandreou C, Koukoulis G, Karasavvidou F, Dimakopoulos G, Weingärtner K, Karatzas A, Zachos I, Tzortzis V.

Pathol Oncol Res. 2019 Jan;25(1):225-231. doi: 10.1007/s12253-017-0340-1. Epub 2017 Oct 28.

PMID:
29081034
26.

Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial.

Papandreou C, Bullò M, Tinahones FJ, Martínez-González MÁ, Corella D, Fragkiadakis GA, López-Miranda J, Estruch R, Fitó M, Salas-Salvadó J.

Nutr Metab (Lond). 2017 Sep 2;14:58. doi: 10.1186/s12986-017-0213-3. eCollection 2017.

27.

Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

Christodoulou C, Kalogera-Fountzila A, Karavasilis V, Kouvatseas G, Papandreou CN, Samantas E, Varaki K, Papadopoulos G, Bobos M, Rallis G, Razis E, Goudopoulou A, Kalogeras KT, Syrigos KN, Fountzilas G.

J Neurooncol. 2017 Sep;134(2):443-451. doi: 10.1007/s11060-017-2548-z. Epub 2017 Jul 7.

PMID:
28687923
28.

Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk.

Dobrosielski DA, Papandreou C, Patil SP, Salas-Salvadó J.

Eur Respir Rev. 2017 Jun 28;26(144). pii: 160110. doi: 10.1183/16000617.0110-2016. Print 2017 Jun 30. Review.

29.

Ludovico Maria Barbieri (1662-1728), the unknown 17th century physician.

Kousoulis AA, Armenis I, Papandreou C, Marinelis A, Marineli F, Tsoucalas G, Androutsos G.

J Med Biogr. 2016 Nov;24(4):524-527. Epub 2015 Feb 19.

PMID:
25697349
30.

Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity.

Vaiou M, Pangou E, Liakos P, Sakellaridis N, Vassilopoulos G, Dimas K, Papandreou C.

J Cancer Res Clin Oncol. 2016 Oct;142(10):2141-58. doi: 10.1007/s00432-016-2216-2. Epub 2016 Aug 16.

PMID:
27530445
31.

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.

Marrero JA, Kudo M, Venook AP, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JH, de Guevara LL, Papandreou C, Takayama T, Sanyal AJ, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R.

J Hepatol. 2016 Dec;65(6):1140-1147. doi: 10.1016/j.jhep.2016.07.020. Epub 2016 Jul 25.

PMID:
27469901
32.

Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.

Liontos M, Trigka EA, Korkolopoulou P, Tzannis K, Lainakis G, Koutsoukos K, Kostouros E, Lykka M, Papandreou CN, Karavasilis V, Christodoulou C, Papatsoris A, Skolarikos A, Varkarakis I, Adamakis I, Alamanis C, Stravodimos K, Mitropoulos D, Deliveliotis C, Constantinidis CA, Saetta A, Patsouris E, Dimopoulos MΑ, Bamias A.

World J Urol. 2017 Mar;35(3):411-419. doi: 10.1007/s00345-016-1890-7. Epub 2016 Jul 9.

PMID:
27395374
33.

Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.

Kotoula V, Karavasilis V, Zagouri F, Kouvatseas G, Giannoulatou E, Gogas H, Lakis S, Pentheroudakis G, Bobos M, Papadopoulou K, Tsolaki E, Pectasides D, Lazaridis G, Koutras A, Aravantinos G, Christodoulou C, Papakostas P, Markopoulos C, Zografos G, Papandreou C, Fountzilas G.

Breast Cancer Res Treat. 2016 Jul;158(2):307-21. doi: 10.1007/s10549-016-3883-z. Epub 2016 Jul 1.

PMID:
27369359
34.

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.

Fountzilas G, Giannoulatou E, Alexopoulou Z, Zagouri F, Timotheadou E, Papadopoulou K, Lakis S, Bobos M, Poulios C, Sotiropoulou M, Lyberopoulou A, Gogas H, Pentheroudakis G, Pectasides D, Koutras A, Christodoulou C, Papandreou C, Samantas E, Papakostas P, Kosmidis P, Bafaloukos D, Karanikiotis C, Dimopoulos MA, Kotoula V.

Oncotarget. 2016 May 31;7(22):32731-53. doi: 10.18632/oncotarget.9022.

35.

The Prognostic Significance of the Hedgehog Signaling Pathway in Colorectal Cancer.

Papadopoulos V, Tsapakidis K, Riobo Del Galdo NA, Papandreou CN, Del Galdo F, Anthoney A, Sakellaridis N, Dimas K, Kamposioras K.

Clin Colorectal Cancer. 2016 Jun;15(2):116-27. doi: 10.1016/j.clcc.2016.02.010. Epub 2016 Feb 16. Review.

PMID:
27032873
36.

Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.

Kudo M, Lencioni R, Marrero JA, Venook AP, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JF, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Yoon SK, Nakajima K, Lehr R, Heldner S, Ye SL.

Liver Int. 2016 Aug;36(8):1196-205. doi: 10.1111/liv.13096. Epub 2016 Apr 1.

PMID:
26901163
37.

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.

Geschwind JF, Kudo M, Marrero JA, Venook AP, Chen XP, Bronowicki JP, Dagher L, Furuse J, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Ye SL, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R.

Radiology. 2016 May;279(2):630-40. doi: 10.1148/radiol.2015150667. Epub 2016 Jan 8.

PMID:
26744927
38.

Mutation profile of KRAS and BRAF genes in patients with colorectal cancer: association with morphological and prognostic criteria.

Samara M, Kapatou K, Ioannou M, Kostopoulou Ε, Papamichali R, Papandreou C, Athanasiadis A, Koukoulis G.

Genet Mol Res. 2015 Dec 14;14(4):16793-802. doi: 10.4238/2015.December.14.6.

39.

Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).

Koutsoukos K, Tzannis K, Christodoulou C, Karavasilis V, Bakoyiannis C, Makatsoris T, Papandreou CN, Pectasides D, Dimopoulos MA, Bamias A.

World J Urol. 2016 Jun;34(6):853-7. doi: 10.1007/s00345-015-1695-0. Epub 2015 Sep 26.

PMID:
26410826
40.

Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders.

Dimitropoulos K, Karatzas A, Papandreou C, Daliani D, Zachos I, Pisters LL, Tzortzis V.

Andrologia. 2016 May;48(4):425-30. doi: 10.1111/and.12462. Epub 2015 Aug 13.

PMID:
26268684
41.

Seven Countries Study cohort in Crete, Greece: gluteal adipose-tissue fatty-acid profiles of survivors, at 2010.

Papandreou C, Kiriakakis M, Fragkiadakis GA, Hatzis CM, Kafatos AG.

Public Health Nutr. 2016 May;19(7):1164-7. doi: 10.1017/S1368980015002335. Epub 2015 Aug 5.

PMID:
26243690
42.

Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study.

Daniele B, Croitoru A, Papandreou C, Bronowicki JP, Mathurin P, Serejo F, Stål P, Turnes J, Ratziu V, Bodoky G.

Future Oncol. 2015 Sep;11(18):2553-62. doi: 10.2217/fon.15.163. Epub 2015 Jul 9.

43.

Adherence to the Mediterranean Diet in Relation to Obesity Indices before and after a Weight Reduction Program in OSAS Patients.

Papandreou C, Hatzis CM.

Iran J Public Health. 2014 Oct;43(10):1454-5. No abstract available.

44.

Effects of different weight loss percentages on moderate to severe obstructive sleep apnoea syndrome.

Papandreou C, Hatzis CM, Fragkiadakis GA.

Chron Respir Dis. 2015 Aug;12(3):276-8. doi: 10.1177/1479972315587516. Epub 2015 May 25. No abstract available.

PMID:
26015461
45.

Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis.

Vlachostergios PJ, Papandreou CN.

Arch Med Sci. 2015 Apr 25;11(2):307-10. doi: 10.5114/aoms.2013.36919. Epub 2013 Aug 12.

46.

Erratum to: Endothelin-1 overexpression: a potential biomarker of unfavorable prognosis in non-metastatic muscle-invasive bladder cancer.

Mitrakas L, Gravas S, Karasavvidou F, Dimakopoulos G, Moutzouris G, Tzortzis V, Koukoulis G, Papandreou C, Melekos M.

Tumour Biol. 2015 Apr;36(4):3127. doi: 10.1007/s13277-015-3286-5. No abstract available.

PMID:
25750035
47.

Targeting neuroendocrine prostate cancer: molecular and clinical perspectives.

Vlachostergios PJ, Papandreou CN.

Front Oncol. 2015 Feb 2;5:6. doi: 10.3389/fonc.2015.00006. eCollection 2015. Review.

48.

Endothelin-1 overexpression: a potential biomarker of unfavorable prognosis in non-metastatic muscle-invasive bladder cancer.

Mitrakas L, Gravas S, Karasavvidou F, Dimakopoulos G, Moutzouris G, Tzortzis V, Koukoulis G, Papandreou C, Melekos M.

Tumour Biol. 2015 Jun;36(6):4699-705. doi: 10.1007/s13277-015-3118-7. Epub 2015 Jan 28. Erratum in: Tumour Biol. 2015 Apr;36(4):3127.

PMID:
25627007
49.

Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study.

Thiery-Vuillemin A, Theodore C, Jacobasch L, Schmitz J, Papandreou C, Guillot A, Emmanouilides C, Slimane K, Kelkouli N, Kim S, Nguyen Tan Hon T.

Clin Genitourin Cancer. 2015 Jun;13(3):231-8. doi: 10.1016/j.clgc.2014.09.005. Epub 2014 Nov 20.

PMID:
25456838
50.

The metabolic syndrome among preschool and school age children and adolescents in Crete in the first decade of the 21st century.

Hatzis CM, Papandreou C, Sifaki-Pistolla D, Jildeh C, Kafatos AG.

Hormones (Athens). 2014 Oct-Dec;13(4):588-90. doi: 10.14310/horm.2002.1522. Epub 2014 Nov 5. No abstract available.

Supplemental Content

Loading ...
Support Center